Kinarus Therapeutics Holding AG announced that its interim-CFO, Mr. Subhasis Roy, who worked as a consultant for the company, is leaving to pursue other opportunities. The CFO role at Kinarus will not be immediately filled. The Companyâs financial controller provides continuity; supported by a new external advisor with significant public market experience, the Company has sufficient competencies and capacity to manage its current finances with the diligence required to properly run a listed company in Switzerland.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15 CHF | -6.99% | -6.99% | +737.05% |
- Stock Market
- Equities
- CURE Stock
- News Kinarus Therapeutics Holding AG
- Kinarus Therapeutics Announces Personnel Changes